KALOUN EL BACHIR,BEDJEGUELAL KARIM,RABOT RÉMI,KRUCZYNSKI ANNA,SCHMITT PHILIPPE,PEREZ MICHEL,RAHIER NICOLAS
申请号：
NZ61443212
公开号：
NZ614432A
申请日:
2012.01.27
申请国别(地区):
NZ
年份:
2015
代理人:
摘要：
The disclosure relates to an azaindazole or diazaindazole derivative compound of formula (I), a pharmaceutically acceptable salt or solvate of same, a tautomer of same, or a stereoisomer or mixture of stereoisomers of same in any proportions, such as a mixture of enantiomers, notably a racemic mixture as well as to the use of same as a drug to the use of same as a kinase inhibitor to the pharmaceutical compositions comprising same and to methods for the preparation of same. These compounds are intended for the treatment of cancer, inflammation and neurodegenerative diseases such as Alzheimer&rsquos disease.
